The situation.
As part of their future planning, the shareholders of Agropharm approached Leith M&A. After meeting David Nelson and receiving a full appraisal of the company’s value and the market, they appointed Leith M&A to run the sale.
Our approach.
Sale documents prepared with the company’s financial and operational directors.
Research identifying around 70 UK and international agrochemical manufacturers that fitted the buyer criteria, plus sector-focused private equity groups.
Confidential approaches to shareholders on the approved list, leading to eight interested parties after site visits and meetings.
Leith M&A chaired every meeting and acted as the single point of contact for all parties.
What made it difficult.
Interest was never the problem. Due diligence was. Strict EU chemicals regulation, overseas subsidiaries, international agent agreements and a freehold site with a wartime history all had to be worked through, including environmental testing and insurance to protect the outgoing shareholders.
The outcome.
Three parties made attractive offers. PelGar International signed heads of terms, and David supported the shareholders through due diligence alongside PelGar’s advisers and Agropharm’s auditors, through to completion.
